Notice2026-22800
National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 9, 2026
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 215 (Monday, November 9, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 215 (Monday, November 9, 2026)]
[Notices]
[Page 70890]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-22800]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin
Diseases; Notice of Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Arthritis
and Musculoskeletal and Skin Diseases Advisory Council.
The meeting will be partially open to the public as indicated
below, with attendance limited to space available. Individuals who plan
to attend and need special assistance, such as sign language
interpretation or other reasonable accommodations, should notify the
Contact Person listed below in advance of the meeting. The open session
will be videocast and can be accessed from the NIH Videocasting and
Podcasting website: <a href="https://videocast.nih.gov/watch/d7d1c3b9-bb39-11f1-82c0-124f0a52e769">https://videocast.nih.gov/watch/d7d1c3b9-bb39-11f1-82c0-124f0a52e769</a>.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Arthritis and Musculoskeletal and
Skin Diseases Advisory Council.
Date: January 26, 2027.
Open: 9:30 a.m. to 3:30 p.m.
Agenda: Call to Order; Consideration of Minutes; NIAMS
Director's Report and Discussion; Concepts; Open Discussion.
Address: National Institutes of Health, 6701 Democracy Blvd.,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Closed: 3:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Address: National Institutes of Health, 6701 Democracy Blvd.,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Timothy Erik Edgerton, MBA, Acting Deputy
Director, Division of Extramural Activities, Grants Management
Branch, Division of Extramural Activities, 6701 Democracy Blvd.,
Suite 838, Bethesda, MD 20892, (301) 594-7760,
<a href="/cdn-cgi/l/email-protection#bedbdad9dbcccad1d0cafed3dfd7d290d0d7d690d9d1c8"><span class="__cf_email__" data-cfemail="c7a2a3a0a2b5b3a8a9b387aaa6aeabe9a9aeafe9a0a8b1">[email protected]</span></a>.
Registration is not required to attend the open portion of this
meeting.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: <a href="https://www.niams.nih.gov/about/working-groups/advisory-council">https://www.niams.nih.gov/about/working-groups/advisory-council</a>, where an agenda and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.846,
Arthritis, Musculoskeletal and Skin Diseases Research; 93.AR4,
Arthritis, Musculoskeletal and Skin Diseases Research--Training
Institutional (TI); 93.AR6, Arthritis, Musculoskeletal and Skin
Diseases Research--Other Research (OR); 93.AR5, Arthritis,
Musculoskeletal and Skin Diseases Research--Research Centers (RC);
93.AR7, Arthritis, Musculoskeletal and Skin Diseases Research--SBIR/
STTR; 93.AR1, Arthritis, Musculoskeletal and Skin Diseases
Research--Research Projects; 93.AR3, Arthritis, Musculoskeletal and
Skin Diseases Research--Training Individual (TR), National
Institutes of Health, HHS)
Dated: November 5, 2026.
Rosalind M. Niamke,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2026-22800 Filed 11-6-26; 8:45 am]
BILLING CODE 4167-05-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on November 9, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.